470 related articles for article (PubMed ID: 18708427)
1. Reversible phenotype in a mouse model of Hutchinson-Gilford progeria syndrome.
Sagelius H; Rosengardten Y; Schmidt E; Sonnabend C; Rozell B; Eriksson M
J Med Genet; 2008 Dec; 45(12):794-801. PubMed ID: 18708427
[TBL] [Abstract][Full Text] [Related]
2. Targeted transgenic expression of the mutation causing Hutchinson-Gilford progeria syndrome leads to proliferative and degenerative epidermal disease.
Sagelius H; Rosengardten Y; Hanif M; Erdos MR; Rozell B; Collins FS; Eriksson M
J Cell Sci; 2008 Apr; 121(Pt 7):969-78. PubMed ID: 18334552
[TBL] [Abstract][Full Text] [Related]
3. Hutchinson-Gilford progeria syndrome.
Pollex RL; Hegele RA
Clin Genet; 2004 Nov; 66(5):375-81. PubMed ID: 15479179
[TBL] [Abstract][Full Text] [Related]
4. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
Glynn MW; Glover TW
Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
[TBL] [Abstract][Full Text] [Related]
5. A progeroid syndrome in mice is caused by defects in A-type lamins.
Mounkes LC; Kozlov S; Hernandez L; Sullivan T; Stewart CL
Nature; 2003 May; 423(6937):298-301. PubMed ID: 12748643
[TBL] [Abstract][Full Text] [Related]
6. Hutchinson-Gilford progeria syndrome: clinical findings in three patients carrying the G608G mutation in LMNA and review of the literature.
Mazereeuw-Hautier J; Wilson LC; Mohammed S; Smallwood D; Shackleton S; Atherton DJ; Harper JI
Br J Dermatol; 2007 Jun; 156(6):1308-14. PubMed ID: 17459035
[TBL] [Abstract][Full Text] [Related]
7. [The role of lamins and mutations of LMNA gene in physiological and premature aging].
Sliwińska MA
Postepy Biochem; 2007; 53(1):46-52. PubMed ID: 17718387
[TBL] [Abstract][Full Text] [Related]
8. A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS.
Denecke J; Brune T; Feldhaus T; Robenek H; Kranz C; Auchus RJ; Agarwal AK; Marquardt T
Hum Mutat; 2006 Jun; 27(6):524-31. PubMed ID: 16671095
[TBL] [Abstract][Full Text] [Related]
9. The truncated prelamin A in Hutchinson-Gilford progeria syndrome alters segregation of A-type and B-type lamin homopolymers.
Delbarre E; Tramier M; Coppey-Moisan M; Gaillard C; Courvalin JC; Buendia B
Hum Mol Genet; 2006 Apr; 15(7):1113-22. PubMed ID: 16481358
[TBL] [Abstract][Full Text] [Related]
10. LMNA mutations in progeroid syndromes.
Huang S; Kennedy BK; Oshima J
Novartis Found Symp; 2005; 264():197-202; discussion 202-7, 227-30. PubMed ID: 15773755
[TBL] [Abstract][Full Text] [Related]
11. Protein farnesyltransferase inhibitors and progeria.
Meta M; Yang SH; Bergo MO; Fong LG; Young SG
Trends Mol Med; 2006 Oct; 12(10):480-7. PubMed ID: 16942914
[TBL] [Abstract][Full Text] [Related]
12. Towards a Drosophila model of Hutchinson-Gilford progeria syndrome.
Beard GS; Bridger JM; Kill IR; Tree DR
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1389-92. PubMed ID: 19021561
[TBL] [Abstract][Full Text] [Related]
13. Progeria, the nucleolus and farnesyltransferase inhibitors.
Mehta IS; Bridger JM; Kill IR
Biochem Soc Trans; 2010 Feb; 38(Pt 1):287-91. PubMed ID: 20074076
[TBL] [Abstract][Full Text] [Related]
14. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis.
Csoka AB; English SB; Simkevich CP; Ginzinger DG; Butte AJ; Schatten GP; Rothman FG; Sedivy JM
Aging Cell; 2004 Aug; 3(4):235-43. PubMed ID: 15268757
[TBL] [Abstract][Full Text] [Related]
15. Stem cell depletion in Hutchinson-Gilford progeria syndrome.
Rosengardten Y; McKenna T; Grochová D; Eriksson M
Aging Cell; 2011 Dec; 10(6):1011-20. PubMed ID: 21902803
[TBL] [Abstract][Full Text] [Related]
16. [A-type lamins and progeroïd syndromes : persistent farnesylation with dramatic effects].
Navarro CL; Poitelon Y; Lévy N
Med Sci (Paris); 2008 Oct; 24(10):833-40. PubMed ID: 18950579
[TBL] [Abstract][Full Text] [Related]
17. Lamin A-linked progerias: is farnesylation the be all and end all?
Smallwood DT; Shackleton S
Biochem Soc Trans; 2010 Feb; 38(Pt 1):281-6. PubMed ID: 20074075
[TBL] [Abstract][Full Text] [Related]
18. p.S143F mutation in lamin A/C: a new phenotype combining myopathy and progeria.
Kirschner J; Brune T; Wehnert M; Denecke J; Wasner C; Feuer A; Marquardt T; Ketelsen UP; Wieacker P; Bönnemann CG; Korinthenberg R
Ann Neurol; 2005 Jan; 57(1):148-51. PubMed ID: 15622532
[TBL] [Abstract][Full Text] [Related]
19. Hutchinson-Gilford progeria syndrome through the lens of transcription.
Prokocimer M; Barkan R; Gruenbaum Y
Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
[TBL] [Abstract][Full Text] [Related]
20. Telomere length in Hutchinson-Gilford progeria syndrome.
Decker ML; Chavez E; Vulto I; Lansdorp PM
Mech Ageing Dev; 2009 Jun; 130(6):377-83. PubMed ID: 19428457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
